Nick Pavlakis
- Oncology top 0.2%
- Pulmonary and Respiratory Medicine top 0.5%
- Molecular Biology top 5%
- Cancer Research top 1%
- Surgery top 5%
- Co-authors
- Stephen ClarkeMartin R. StocklerNico van ZandwijkMichael BoyerSteven KaoMatthew H. WongAnthony J. GillRoss Davey
- Topics
- Lung Cancer Treatments and Mutations (82 papers)Colorectal Cancer Treatments and Studies (66 papers)Lung Cancer Research Studies (64 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Nick Pavlakis
298 papers receiving 8.4k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Oncology 4.9k
- Pulmonary and Respiratory Medicine 3.5k
- Molecular Biology 1.9k
- Cancer Research 1.6k
- Surgery 995
Countries citing papers authored by Nick Pavlakis
This map shows the geographic impact of Nick Pavlakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Pavlakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Pavlakis more than expected).
Fields of papers citing papers by Nick Pavlakis
This network shows the impact of papers produced by Nick Pavlakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Pavlakis. The network helps show where Nick Pavlakis may publish in the future.
Co-authorship network of co-authors of Nick Pavlakis
This figure shows the co-authorship network connecting the top 25 collaborators of Nick Pavlakis. A scholar is included among the top collaborators of Nick Pavlakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick Pavlakis. Nick Pavlakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 24 | |
| 6 | 1 | |
| 7 | 24 | |
| 8 | 14 | |
| 9 | 82 | |
| 10 | 2 | |
| 11 | 3 | |
| 12 | 5 | |
| 13 | Patient Interviews in TELESTAR, a Phase 3 Study of Telotristat Etiprate, Report Meaningful Improvement in Carcinoid Syndrome | 1 |
| 14 | Assessing Treatment Benefit of Telotristat Etiprate in Patients with Carcinoid Syndrome : Patient Exit Interviews | 1 |
| 15 | Rare molecular subsets among lung tumours - what makes them stand apart from the common? | 0 |
| 16 | 20 | |
| 17 | 33 | |
| 18 | THE ADDITION OF ANTI-ANGIOGENIC TYROSINE KINASE INHIBITORS TO CHEMOTHERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS | 1 |
| 19 | 86 | |
| 20 | Patterns of outcome and prognostic factors in primary bone lymphoma (osteolymphoma): A survey of 499 cases by the international extranodal lymphoma study group | 3 |
About Nick Pavlakis
Nick Pavlakis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 307 papers that have together received 8.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (82 papers), Colorectal Cancer Treatments and Studies (66 papers) and Lung Cancer Research Studies (64 papers). The work is most often cited by research in Oncology (4.9k citations), Pulmonary and Respiratory Medicine (3.5k citations) and Cancer Research (1.6k citations). Nick Pavlakis has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Stephen Clarke, Martin R. Stockler, Nico van Zandwijk, Michael Boyer, Steven Kao, Matthew H. Wong, Anthony J. Gill, Ross Davey, Britta Stordal and Janette L. Vardy. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.